Item 4. Ownership.
(a) Amount Beneficially Owned:
As of December 31, 2000: HCV II and HCP II beneficially owned
immediately exercisable warrants to purchase 78,877 Shares of the
Issuers Common Stock; HCV III and HCP III beneficially owned
immediately exercisable warrants to purchase 99,705 Shares of the
Issuer's Common Stock; HCV IV and HCP IV beneficially owned
immediately exercisable warrants to purchase 29,571 Shares of the
Issuer's Common Stock; Dr. Cavanaugh and Messrs. Werner and
Littlechild beneficially owned immediately exercisable warrants to
purchase 208,153 Shares of the Issuer's Common Stock; and Mr. Crouse
beneficially owned 235,351 Shares of the Issuer's Securities,
consisting of 19,698 Shares of the Issuer's Common Stock,
immediately exercisable warrants to purchase 208,153 Shares of
Issuer's Common Stock, and immediately exercisable options to
purchase 7,500 Shares of the Issuer's Common Stock(2)
(b) Percent of Class:
As of December 31, 2000: the immediately exercisable warrants to
purchase 78,877 Shares of the Issuer's Common Stock beneficially
owned by HCV II and HCP II constitute .67% of the Issuer's Shares
outstanding; the immediately exercisable warrants to purchase 99,705
Shares of Issuer's Common Stock beneficially owned by HCV III and
HCP III constitute .85% of the Issuer's Shares outstanding; the
immediately exercisable warrants to purchase 29,571 Shares of the
Issuer's Common Stock beneficially owned by HCV IV and HCP IV
constitute .25% of the Issuer's Shares outstanding; the immediately
exercisable warrants to purchase 208,153 Shares of the Issuer's
Securities beneficially owned by Dr. Cavanaugh and Messrs. Werner
and Littlechild constitute 1.77% of the Issuer's Shares outstanding;
and the 235,351 Shares of Issuer's Securities beneficially owned by
Mr. Crouse constitute 2.0% of Issuer's Shares outstanding.
--------
(2) Does not include options to purchase 14,125 shares of the Common
Stock of the Issuer which were granted to Mr. Crouse as a director
of the Issuer and are not immediately exercisable.
Page 14 of 19 pages
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
Mr. Crouse has the sole power to vote or direct the vote as to
the 27,198 Shares owned by him.
(ii) shared power to vote or to direct the vote:
HCV II, HCP II, Dr. Cavanaugh and Messrs. Werner, Littlechild
and Crouse share the power to vote or direct the vote of those
Shares owned by HCV II.
HCV III, HCP III, Dr. Cavanaugh and Messrs. Werner,
Littlechild and Crouse share the power to vote or direct the
vote of those Shares owned by HCV III.
HCV IV, HCP IV, Dr. Cavanaugh and Messrs. Werner, Littlechild
and Crouse share the power to vote or direct the vote of those
Shares owned by HCV IV.
(iii) sole power to dispose or to direct the disposition of:
Mr. Crouse has the sole power to dispose or to direct the
disposition as to the 27,198 Shares directly owned by him.
(iv) shared power to dispose of or to direct the disposition of:
HCV II, HCP II, Dr. Cavanaugh and Messrs. Werner, Littlechild
and Crouse share the power to dispose of or direct the
disposition of those Shares owned by HCV II.
HCV III, HCP III, Dr. Cavanaugh and Messrs. Werner,
Littlechild and Crouse share the power to dispose of or direct
the disposition of those Shares owned by HCV III.
HCV IV, HCP IV, Dr. Cavanaugh and Messrs. Werner, Littlechild
and Crouse share the power to dispose of or direct the
disposition of those Shares owned by HCV IV.
Item 5. Ownership of Five Percent or less of a Class:
This Statement is being filed to report the fact that as of the date
hereof, the reporting person has ceased to be the beneficial owner
of more than five percent of the class of securities being reported
herein. |
